Home/Filings/4/0001213900-25-116306
4//SEC Filing

Schneiderman Daniel H 4

Accession 0001213900-25-116306

CIK 0001841330other

Filed

Nov 30, 7:00 PM ET

Accepted

Dec 1, 9:04 AM ET

Size

4.5 KB

Accession

0001213900-25-116306

Insider Transaction Report

Form 4
Period: 2025-11-28
Schneiderman Daniel H
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2025-11-28$0.75/sh+26,667$20,00026,667 total

Documents

1 file

Issuer

Pasithea Therapeutics Corp.

CIK 0001841330

Entity typeother

Related Parties

1
  • filerCIK 0001565536

Filing Metadata

Form type
4
Filed
Nov 30, 7:00 PM ET
Accepted
Dec 1, 9:04 AM ET
Size
4.5 KB